BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chang FY. Irritable bowel syndrome: The evolution of multi-dimensional looking and multidisciplinary treatments. World J Gastroenterol 2014; 20(10): 2499-2514 [PMID: 24627587 DOI: 10.3748/wjg.v20.i10.2499] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 21] [Article Influence: 3.7] [Reference Citation Analysis]
Number Citing Articles
1 Marynowski M, Likońska A, Zatorski H, Fichna J. Role of environmental pollution in irritable bowel syndrome. World J Gastroenterol 2015; 21(40): 11371-11378 [PMID: 26523104 DOI: 10.3748/wjg.v21.i40.11371] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
2 Mosińska P, Fichna J, Storr M. Inhibition of ileal bile acid transporter: An emerging therapeutic strategy for chronic idiopathic constipation. World J Gastroenterol 2015; 21(24): 7436-7442 [PMID: 26139989 DOI: 10.3748/wjg.v21.i24.7436] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
3 Scarpellini E, Laterza L, Ianiro G, Tack J, Abenavoli L, Gasbarrini A. Eluxadoline for the treatment of diarrhoea-predominant irritable bowel syndrome. Expert Opin Pharmacother 2016;17:1395-402. [PMID: 27267380 DOI: 10.1080/14656566.2016.1182982] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
4 Bellini M, Gambaccini D, Bassotti G. Comorbidities in functional gastrointestinal diseases: Do we need a lone ranger or a dream team? Dig Liver Dis 2016;48:562-4. [PMID: 27005860 DOI: 10.1016/j.dld.2016.02.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
5 Sherwin LB, Leary E, Henderson WA. Effect of Illness Representations and Catastrophizing on Quality of Life in Adults With Irritable Bowel Syndrome. J Psychosoc Nurs Ment Health Serv. 2016;54:44-53. [PMID: 27576228 DOI: 10.3928/02793695-20160803-01] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
6 Piche T, Pishvaie D, Tirouvaziam D, Filippi J, Dainese R, Tonohouhan M, Degalleani L, Nébot-vivinus M, Payrouse J, Hébuterne X. Osteopathy decreases the severity of IBS-like symptoms associated with Crohn’s disease in patients in remission. European Journal of Gastroenterology & Hepatology 2014;26:1392-8. [DOI: 10.1097/meg.0000000000000219] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
7 Grosjean D, Benini P, Carayon P. Managing irritable bowel syndrome: The impact of micro-physiotherapy. J Complement Integr Med 2017;14:/j/jcim. [PMID: 28306531 DOI: 10.1515/jcim-2015-0044] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Schatz RA, Moshiree B. Gastrointestinal and Hepatic Disease in Fibromyalgia. Rheum Dis Clin North Am 2018;44:131-42. [PMID: 29149921 DOI: 10.1016/j.rdc.2017.09.009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Patel S, Doerfler B, Boutros K, Ng S, Manuel M, DeSimone E. Review of Treatment Options for Irritable Bowel Syndrome with Constipation and Chronic Idiopathic Constipation. Int J Gen Med 2021;14:1457-68. [PMID: 33907450 DOI: 10.2147/IJGM.S274568] [Reference Citation Analysis]
10 Wang FY, Su M, Zheng YQ, Wang XG, Kang N, Chen T, Zhu EL, Bian ZX, Tang XD. Herbal prescription Chang'an II repairs intestinal mucosal barrier in rats with post-inflammation irritable bowel syndrome. Acta Pharmacol Sin 2015;36:708-15. [PMID: 25960135 DOI: 10.1038/aps.2014.170] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
11 Liu L, Liu BN, Chen S, Wang M, Liu Y, Zhang YL, Yao SK. Visceral and somatic hypersensitivity, autonomic cardiovascular dysfunction and low-grade inflammation in a subset of irritable bowel syndrome patients. J Zhejiang Univ Sci B. 2014;15:907-914. [PMID: 25294380 DOI: 10.1631/jzus.b1400143] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
12 Yazdani M, Aramesh A, Rafiei R, Daghaghzadeh H, Adibi P. The comparison of treatments with and without azithromycin in irritable bowel syndrome with diarrhea-predominant in gastrointestinal Clinic of Al-Zahra Hospital, Isfahan, Iran. Adv Biomed Res 2016;5:188. [PMID: 28028528 DOI: 10.4103/2277-9175.192737] [Reference Citation Analysis]
13 Schmulson MJ, Chiu-Ugalde J, Sáez-Ríos A, López-Colombo A, Mateos-Pérez GJ, Remes-Troche JM, Sobrino-Cossio S, Soto-Pérez JC, Tamayo de la Cuesta JL, Teramoto-Matsubara OT, López-Alvarenga JC. Efficacy of the Combination of Pinaverium Bromide 100 mg Plus Simethicone 300 mg in Abdominal Pain and Bloating in Irritable Bowel Syndrome: A Randomized, Placebo-controlled Trial. J Clin Gastroenterol 2020;54:e30-9. [PMID: 31385885 DOI: 10.1097/MCG.0000000000001242] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
14 Li Q, Zhang BP, Huang SG, Ouyang WW, Xie JH, Wen ZH, Yang XB. Efficacy and indication optimization of Chinese medicine (Tiao-Chang Ke-Min granules) for diarrhea-predominant irritable bowel syndrome: study protocol for a randomized controlled trial. Trials 2018;19:367. [PMID: 29996882 DOI: 10.1186/s13063-018-2754-9] [Reference Citation Analysis]
15 Kim M, Dam A, Green J. Common GI Drug Interactions in the Elderly. Curr Treat Options Gastroenterol 2014;12:292-309. [PMID: 25031070 DOI: 10.1007/s11938-014-0024-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
16 Li CY, Li SC. Treatment of irritable bowel syndrome in China: A review. World J Gastroenterol 2015; 21(8): 2315-2322 [PMID: 25741137 DOI: 10.3748/wjg.v21.i8.2315] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
17 Lan L, Chen YL, Zhang H, Jia BL, Chu YJ, Wang J, Tang SX, Xia GD. Efficacy of tandospirone in patients with irritable bowel syndrome-diarrhea and anxiety. World J Gastroenterol 2014; 20(32): 11422-11428 [PMID: 25170231 DOI: 10.3748/wjg.v20.i32.11422] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
18 Ooi SL, Correa D, Pak SC. Probiotics, prebiotics, and low FODMAP diet for irritable bowel syndrome - What is the current evidence? Complement Ther Med 2019;43:73-80. [PMID: 30935559 DOI: 10.1016/j.ctim.2019.01.010] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 11.5] [Reference Citation Analysis]
19 Kaur T, Shyu B. Melatonin: A New-Generation Therapy for Reducing Chronic Pain and Improving Sleep Disorder-Related Pain. In: Shyu B, Tominaga M, editors. Advances in Pain Research: Mechanisms and Modulation of Chronic Pain. Singapore: Springer; 2018. pp. 229-51. [DOI: 10.1007/978-981-13-1756-9_19] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
20 Zhou HH, Zhang YM, Zhang SP, Xu QX, Tian YQ, Li P, Cao D, Zheng YQ. Suppression of PTRF Alleviates Post-Infectious Irritable Bowel Syndrome via Downregulation of the TLR4 Pathway in Rats. Front Pharmacol 2021;12:724410. [PMID: 34690766 DOI: 10.3389/fphar.2021.724410] [Reference Citation Analysis]
21 Chandar AK. Diagnosis and treatment of irritable bowel syndrome with predominant constipation in the primary-care setting: focus on linaclotide. Int J Gen Med 2017;10:385-93. [PMID: 29184433 DOI: 10.2147/IJGM.S126581] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]